研究论文
Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
Shani Ben‐Shlomo, Isabel Zvibel, Mati Shnell, Amir Shlomai, Elena Chepurko, Zamir Halpern, Nir Barzilai, Ran Oren 等 9 位
Tel Aviv Sourasky Medical Center Albert Einstein College of Medicine
来源Journal of Hepatology
年份2010
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
28140
2817
18
19
20
21
22
23
24
25
26
关键指标
326
被引次数 · OpenAlex
6.21
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 3%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
34
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Diabetes Treatment and Management
Pancreatic function and diabetes · Liver Disease Diagnosis and Treatment
参考文献 34
Pancreatic and extrapancreatic effects of GLP-1.
被引 30Isabel Valverde, María Villanueva-Peñacarrillo, W. J. Malaisse · PubMed · 2002
Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases
被引 268O Gressner, Axel M. Gressner · Liver International · 2008
Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C
被引 34Caroline Hora, Francesco Negro, Gioacchino Leandro · Liver International · 2007
此处列出前 3 条
引用本文 326
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
被引 2,168Matthew J. Armstrong, Piers Gaunt, Guruprasad P. Aithal · The Lancet · 2015
Non-alcoholic fatty liver disease and diabetes
被引 538Jonathan Hazlehurst, Conor Woods, Thomas Marjot · Metabolism · 2016
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
被引 498Darleen A. Sandoval, David A. D’Alessio · Physiological Reviews · 2015
按被引量排序，此处列出前 3 条